芝商所(CME)
![icon](https://files.reportify.cn/fe-static/_next/static/media/search.b3fd6117.png?imageMogr2/quality/75/thumbnail/64x/format/webp)
搜索文档
CME Group(CME) - 2022 Q4 - Annual Report
2023-02-27 00:00
长期债务评级 - 公司长期债务目前被两家主要评级机构评为投资级别[212] 衍生品业务费率波动 - 公司的衍生品业务每份合同的平均费率会因多种因素波动,难以预测未来的平均费率[214] 董事会交易权益 - 公司董事会中有十位成员拥有交易权益,可能会对公司运营产生重大影响[216] 会员交易量影响 - 公司的衍生品业务中83%的合约交易量来自会员,这可能影响公司运营[217] 交易所会员特殊权利 - 公司的交易所会员拥有特殊权利,保护他们的交易特权[220] 金融保障方案 - 公司维持两个独立的金融保障方案,用于应对潜在的清算风险[357] 外汇交易风险 - 公司在外汇交易方面面临着货币兑换风险,可能会导致外汇交易损益波动[368] 外汇汇率波动影响 - 公司外国子公司的财务报表会受到外汇汇率波动的影响[369] 外币兑换风险关注点 - 公司对外币兑换风险的关注点在于客户抵押品[370] 存款市场价值核算 - 公司每日对所有存款进行市场价值核算[370] 外币汇率变动风险 - 公司要求清算公司支付因外币汇率和价格变动导致抵押品价值下降的款项[370] 绩效保证金存款外币风险 - 公司认为与绩效保证金存款相关的外币风险很小,不会对财务状况或运营结果产生重大影响[370]
CME Group(CME) - 2022 Q4 - Earnings Call Transcript
2023-02-09 01:50
John Pietrowicz - Chief Financial Officer Owen Lau - Oppenheimer Customer demand continued to drive our industry leading products and services innovation throughout the year. We enhanced our Micro product suite with additional contracts and in aggregate the Micros contributed nearly 3.5 million contracts of ADV to the overall record activity. During the year, we further invested in our S&P Dow Jones Indices joint venture to expand its offerings to include leading fixed income and credit indices. Our joint v ...
CME Group(CME) - 2023 Q4 - Earnings Call Presentation
2023-02-09 01:49
• SOFR and Treasury options were added into CME Group's Portfolio Margining with OTC Swaps on December 12, 2022. Client average daily savings were $8.4 billion in 4Q22 • December SOFR futures RPC is closely approaching legacy Eurodollar futures RPC With significant rally of the U.S. dollar throughout most of 2022, and varying pace of global central bank policies causing interest rate differentials, the global foreign exchange market is in a highervolatility environment and CME Group FX ADV has come alive in ...
CME Group(CME) - 2022 Q3 - Quarterly Report
2022-11-02 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission fi ...
CME Group(CME) - 2022 Q3 - Earnings Call Transcript
2022-10-27 01:20
CME Group, Inc. (NASDAQ:CME) Q3 2022 Earnings Conference Call October 26, 2022 8:30 AM ET Company Participants John Peschier - MD, IR Terrence Duffy - Chairman & CEO Sean Tully - Senior MD and Global Head, Rates & OTC Products Tim McCourt - Senior MD & Global Head, Equity & FX Products Derek Sammann - Senior MD and Global Head, Commodities, Options & International Markets John Pietrowicz - CFO Julie Winkler - Senior MD & Chief Commercial Officer Sunil Cutinho - Chief Information Officer Conference Call Part ...
CME Group(CME) - 2022 Q2 - Quarterly Report
2022-08-03 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file nu ...
CME Group(CME) - 2022 Q2 - Earnings Call Transcript
2022-07-27 22:36
CME Group Inc. (NASDAQ:CME) Q2 2022 Earnings Conference Call July 27, 2022 8:30 AM ET Company Participants John Peschier - Investor Relations Terry Duffy - Chairman & Chief Executive Officer John Pietrowicz - Chief Financial Officer Lynne Fitzpatrick - Senior Managing Director & Deputy Chief Financial Officer Sean Tully - Senior Managing Director, Financial and OTC Products Derek Sammann - Senior Managing Director, Commodity & Options Products Julie Winkler - Chief Commercial Officer Sunil Cutinho - Preside ...
CME Group(CME) - 2022 Q1 - Quarterly Report
2022-05-04 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n ...
CME Group(CME) - 2022 Q1 - Earnings Call Transcript
2022-04-28 00:19
CME Group Inc. (NASDAQ:CME) Q1 2022 Earnings Conference Call April 27, 2022 8:30 AM ET Company Participants John Peschier – Managing Director-Investor Relations Terry Duffy – Chairman and Chief Executive Officer John Pietrowicz – Chief Financial Officer Julie Winkler – Chief Commercial Officer Sunil Cutinho – Chief Information Officer Derek Sammann – Senior Managing Director, Global Head-Commodities, Options and International Sean Tully – Senior Managing Director, Global Head-Rates and OTC Products Confere ...
CME Group(CME) - 2021 Q4 - Annual Report
2022-02-25 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-K _________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ChicagoIllinois | --- | --- | |-----------------------|-------| | | | | | | | ...